Invasive lobular carcinoma of the breast is known to produce intracellular mucin and has been recognized in single-case reports to show extracellular mucin production, as well. This latter morphology is not only rare but must also be under- or misdiagnosed. The aim was to better characterize this entity. Cases of lobular cancers demonstrating extracellular mucin formation were identified in a multi-institutional effort and their clinical and morphologic features were assessed. Immunohistochemistry was used to characterize the E-cadherin-membrane complex, neuroendocrine differentiation, and to some extent, mucin formation. All but one of the eight cases occurred in postmenopausal patients. Extracellular mucin production was present in 5 to 50% of the tumour samples and rarely also appeared in nodal and distant metastases. The tumours were completely E-cadherin negative and showed cytoplasmic p120 positivity. The majority (n = 6/8) was also completely negative for β-catenin, but two tumours displayed focal β-catenin positivity in the mucinous area. MUC1 and MUC2 expression was observed in all and 7/8 tumours, respectively; neuroendocrine differentiation was present in only one. Invasive lobular carcinoma with extracellular mucin formation is a rare morphologic variant of lobular carcinoma prone to be misdiagnosed and warranting further studies.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Foote FW Jr, Stewart FW (1941) Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol 17:491–496
Fechner RE (1975) Histologic variants of infiltrating lobular carcinoma of the breast. Hum Pathol 6:373–378
Steinbrecher JS, Silverberg SG (1976) Signet-ring cell carcinoma of the breast. The mucinous variant of infiltrating lobular carcinoma? Cancer 37:828–840
Fisher ER, Gregorio RM, Redmond C, Fisher B (1977) Tubulolobular invasive breast cancer: a variant of lobular invasive cancer. Hum Pathol 8:679–683
Martinez V, Azzopardi JG (1979) Invasive lobular carcinoma of the breast: incidence and variants. Histopathology 3:467–488
Page DL, Anderson TJ, eds (1987) Diagnostic histopathology of the breast. Churchill Livingstone, Edinburgh
Weidner N, Semple JP (1992) Pleomorphic variant of invasive lobular carcinoma of the breast. Hum Pathol 23:1167–1171
Eusebi V, Magalhaes F, Azzopardi JG (1992) Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation. Hum Pathol 23:655–662
Amendoeira I, Apostolikas N, Bellocq JP et al (2006) Quality assurance guidelines for pathology. In: Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L (eds) European guidelines for quality assurance in breast cancer screening and diagnosis, 4th edn. European Comission, Luxemburg, pp 219–311
Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ (eds) (2012) WHO classification of tumours of the breast. International Agency for Research on Cancer, Lyon
Tavassoli FA, Eusebi V (2009) Tumors of the mammary gland. Armed Forces Institute of Pathology Atlas of tumor pathology, Series 4. American Registry of Pathology, Washington, DC
Cserni G (1999) Reproducibility of a diagnosis of invasive lobular carcinoma. J Surg Oncol 70:217–221
Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ (2001) Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 115:85–98
Kovács A, Dhillon J, Walker RA (2003) Expression of P-cadherin, but not E-cadherin or N-cadherin, relates to pathological and functional differentiation of breast carcinomas. Mol Pathol 56:318–322
Rakha EA, Abd El Rehim D, Pinder SE, Lewis SA, Ellis IO (2005) E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance. Histopathology 46:685–693
Da Silva L, Parry S, Reid L, Keith P, Waddell N, Kossai M, Clarke C, Lakhani SR, Simpson PT (2008) Aberrant expression of E-cadherin in lobular carcinomas of the breast. Am J Surg Pathol 32:773–783
Rakha EA, Teoh TK, Lee AH, Nolan CC, Ellis IO, Green AR (2013) Further evidence that E-cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study. Histopathology 62:695–701
Canas-Marques R, Schnitt SJ (2016) E-cadherin immunohistochemistry in breast pathology: uses and pitfalls. Histopathology 68:57–69
Rosa M, Mohammadi A, Masood S (2009) Lobular carcinoma of the breast with extracellular mucin: new variant of mucin-producing carcinomas? Pathol Int 59:405–409
Yu J, Bhargava R, Dabbs DJ (2010) Invasive lobular carcinoma with extracellular mucin production and HER-2 overexpression: a case report and further case studies. Diagn Pathol 5:36
Haltas H, Bayrak R, Yenidunya S, Kosehan D, Sen M, Akin K (2012) Invasive lobular carcinoma with extracellular mucin as a distinct variant of lobular carcinoma: a case report. Diagn Pathol 7:91
Bari VB, Bholay SU, Sane KC (2015) Invasive lobular carcinoma of the breast with extracellular mucin. A new rare variant J Clin Diagn Res 9:ED05–ED06
Gomez Macias GS, Pérez Saucedo JE, Cardona Huerta S, Garza Montemayor M, Villarreal Garza C, Garcia Hernandez I (2016) Invasive lobular carcinoma of the breast with extracellular mucin: a case report. Int J Surg Case Rep 25:33–36
Hammond ME, Hayes DF, Dowsett M et al (2010) American Society of ClinicalOncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med 134:e48–e72
Wolff AC, Hammond ME, Hicks DG et al (2014) Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update. Arch Pathol Lab Med 138:241–256
Tot T (2007) Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections. Cancer 110:2551–2560
Bratthauer GL, Moinfar F, Stamatakos MD et al (2002) Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Hum Pathol 33:620–627
Gad A, Azzopardi JG (1975) Lobular carcinoma of the breast: a special variant of mucin-secreting carcinoma. J Clin Pathol 28:711–716
Eusebi V, Azzopardi JG (1980) Lobular endocrine neoplasia in fibroadenoma of the breast. Histopathology 4:413–428
Sapino A, Righi L, Cassoni P, Papotti M, Pietribiasi F, Bussolati G (2000) Expression of the neuroendocrine phenotype in carcinomas of the breast. Semin Diagn Pathol 17:127–137
Capella C, Eusebi V, Mann B, Azzopardi JG (1980) Endocrine differentiation in mucoid carcinoma of the breast. Histopathology 4:613–630
Tan PH, Schnitt SJ, van de Vijver MJ, Ellis IO, Lakhani SR (2015) Papillary and neuroendocrine breast lesions: the WHO stance. Histopathology 66:761–770
Wargotz ES, Norris HJ (1989) Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Hum Pathol 20:628–635
Asioli S, Marucci G, Ficarra G, Stephens M, Foschini MP, Ellis IO, Eusebi V (2006) Polymorphous adenocarcinoma of the breast. Report of three cases. Virchows Arch 448:29–34
Petersson F, Putti TC (2010) Multifocal matrix-producing mammary carcinoma mimicking lobular carcinoma on core biopsy - a case with long survival reported. Pathol Res Pract 206:527–531
Nicol KK, Iskandar SS (2000) Lobular carcinoma of the breast metastatic to the oral cavity mimicking polymorphous low-grade adenocarcinoma of the minor salivary glands. Arch Pathol Lab Med 124:157–159
Jambal P, Badtke MM, Harrell JC, Borges VF, Post MD, Sollender GE, Spillman MA, Horwitz KB, Jacobsen BM (2013) Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features. Breast Cancer Res Treat 137:431–448
The authors thank the help of Drs. Susanne Zöch and Sigurd Lax (Landeskrankenhaus Graz Süd-West, Graz, Austria); Dr. Vasiliki Zolota (University of Patras, Greece); Dr. Georgia Kafiri (Hippokrateio Hospital of Athens, Greece); Dr. Paivi Heikkila (University of Helsinki, Finland); Drs. Celia Perdaens and Veerle Delvaux (Jan Portaels Hospital, Vilvvorde, Belgium); and Dr. Janina Kulka (Semmelweis University, Budapest, Hungary) for their help in collecting the cases and or relevant clinical details. This study was partially funded by the National Research, Development and Innovation Office grant GINOP-2.3.2-15-2016-00020.
The authors have consulted the journal policy regarding compliance with ethical standards and state that accepted principles of ethical and professional conduct have been followed. The authors include information regarding sources of funding and potential conflicts of interest (financial or non-financial). Ethical approval and informed consent related information (waiver for this particular study) are summarized in the final paragraph of the “Material and Methods”. The study did not include animals, therefore issues relating to animal welfare do not apply.
This study was partially funded by the National Research, Development and Innovation Office grant GINOP-2.3.2-15-2016-00020.
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
About this article
Cite this article
Cserni, G., Floris, G., Koufopoulos, N. et al. Invasive lobular carcinoma with extracellular mucin production—a novel pattern of lobular carcinomas of the breast. Clinico-pathological description of eight cases. Virchows Arch 471, 3–12 (2017). https://doi.org/10.1007/s00428-017-2147-6
- Breast cancer
- Extracellular mucin
- Lobular carcinoma
- Mucinous carcinoma